Physician profile
Jeffrey A Feld
NPI 1285764761
$938.58
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $453 · 2020: $14.31 · 2021: $20.91 · 2022: $69.31 · 2023: $154 · 2024: $79.50 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $269 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $269.16 |
| Education | $112.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $452.89 | 2019 | |
| Horizon Therapeutics Plc | $129.62 | 2022-2023 | Krystexxa |
| Djo, LLC | $112.00 | 2025 | Dr Comfort |
| Paratek Pharmaceuticals, INC. | $76.10 | 2021-2025 | Nuzyra |
| Organogenesis INC. | $42.96 | 2023-2024 | Puraply Franchise, Puraply |
| Bioventus LLC | $33.82 | 2022 | |
| Convatec INC. | $25.15 | 2023 | |
| Cashflow Solutions, LLC | $18.02 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Fidia Pharma USA INC. | $17.02 | 2022 | |
| Dynasplint Systems INC. | $16.69 | 2025 | Dynasplint |
| Smith+Nephew, INC. | $14.31 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Feld listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.